
Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Insugen 30/70 Solution for Injection 40IU/ml
(Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%))
Uses, side effects, dosage information & price range
About this medicine
Insugen 30/70 Solution for Injection 40IU/ml is a combination of two medicines, an intermediate-acting and a short-acting type of insulin, used to improve blood sugar control in adults and children with type 1 and type 2 diabetes mellitus. It maintains blood sugar levels in adults and children.Insug
What are the side effects of Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%) (Insugen 30/70 Solution for Injection 40IU/ml)?
Not everyone experiences these side effects. Consult your doctor if any persist.
- Hypoglycemia(low blood glucose level)
- Injection site allergic reaction
- Lipodystrophy(skin thickening or pits at the injection site)
- Itching
- Rash
Common Brand Names for this Composition
The following popular commercial brand names contain Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%) as their active ingredient composition:
Insugen 30/70 Solution for Injection 40IU/ml
Biocon
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
Insulin Isophane/NPH (70%) + Human Insulin/Soluble Insulin (30%)
Category
Human Insulins And Analogues
Manufacturer
Biocon
Price (MRP)
₹133.36
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.